Cordis Selution SLR PTA Drug-Eluting Balloon Launched in Japan 

May 6, 2026—Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon (DEB) for the treatment of peripheral artery disease.

QoL Analysis Reported From PROMISE III Trial of Transcatheter Arterialization of the Deep Veins for CLTI

May 6, 2026—Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment options experienced significant quality of life (QoL) improvements after undergoing transcatheter arterialization of the deep veins (TADV).

Teleflex Appoints Jason Weidman as President and CEO

May 6, 2026—Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026.

CARPOOL Study Compares Radial and Femoral Access for PAD Treatment

May 6, 2026—In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common femoral artery (CFA) access for lower extremity peripheral artery disease (PAD) revascularization.

Solaris DE Drug-Eluting Covered Stent Receives FDA Breakthrough Device Designation

May 5, 2026—Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting covered stent.

ENGULF Analysis Shows Reduced Blood Loss With E2’s Hēlo System in PE Procedures

May 4, 2026—A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy dramatically reduced blood loss by 97%, while maintaining hemodynamic efficacy and improving procedural efficiency.

FDA Awards IDE for Pivotal Study of enVVeno’s Venous Valve to Treat Severe Deep CVI

May 1, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the company’s enVVe transcatheter venous valve endoprosthesis (TAVVE) in the United States.

Cydar Maps Planning and Navigation Solution Expanded to Enable Use in Complex Branched and Visceral Cases

April 29, 2026—Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded release of Cydar Maps.